• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用生活质量-8维度(AQoL-8D)多属性效用工具测量澳大利亚多发性硬化症患者的健康相关生活质量。

Measuring the health-related quality of life in Australians with multiple sclerosis using the assessment of quality of life-8-dimension (AQoL-8D) multi-attribute utility instrument.

作者信息

Ahmad Hasnat, van der Mei Ingrid, Taylor Bruce V, Campbell Julie A, Palmer Andrew J

机构信息

Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool Street, Hobart, TAS 7000, Australia.

Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool Street, Hobart, TAS 7000, Australia.

出版信息

Mult Scler Relat Disord. 2020 Sep;44:102358. doi: 10.1016/j.msard.2020.102358. Epub 2020 Jul 3.

DOI:10.1016/j.msard.2020.102358
PMID:32650122
Abstract

BACKGROUND

Health-related quality of life (HRQoL) has not been assessed in Australians with multiple sclerosis (MS) using a preferentially sensitive multi-attribute utility instrument.

OBJECTIVES

To assess HRQoL and to quantify the impact of disability on health state utility values (HSUVs), and the physical and psychosocial health of people with MS using the Assessment of Quality of Life-8-Dimension (AQoL-8D) instrument.

METHODS

We estimated HSUVs and the unique composite individual and super dimensional (physical and psychosocial) scores of the AQoL-8D for a large, representative sample (n=1,577) of Australians with MS. The estimates were compared to Australian general population norms and broken down by disability severity, classified as no disability (Expanded Disability Status Scale [EDSS] level: 0), mild (EDSS: 1-3.5), moderate (EDSS: 4-6) and severe (EDSS: 6.5-9.5). A multivariable regression model adjusted the association between MS disability severity and HSUVs for age, sex, MS onset type, DMTs usage status, and MS duration.

RESULTS

Mean overall HSUV at 0.61 (95% confidence interval [CI]: 0.60-0.62) was 0.18 units lower than the Australian population norm. HSUV decreased with increasing disability severity: 0.81 (95% CI: 0.80-0.83), 0.65 (95% CI: 0.63-0.67), 0.54 (95% CI: 0.52-0.56) and 0.48 (95% CI: 0.46-0.50) for no, mild, moderate and severe disability, respectively. The mean Physical super-dimension score of 0.57 (95% CI: 56-0.58) was 0.21 units lower than the Australian norm and the Psychosocial super-dimension of 0.33(95% CI: 32-0.34) was 0.16 units lower. Lower HRQoL was primarily driven by reduced scores on Independent living (-0.23), Pain (-0.15), Relationships (-0.13), Coping (-0.12), and Self-worth (-0.12).

CONCLUSIONS

MS impacts all aspects of HRQoL. Effective pain management and support to maintain independent living, relationships, and self-worth can significantly improve the HRQoL of people with MS. Early diagnosis and affordable access to effective treatments to slow or prevent disability accumulation may also be helpful.

摘要

背景

尚未使用优先敏感的多属性效用工具对澳大利亚多发性硬化症(MS)患者的健康相关生活质量(HRQoL)进行评估。

目的

使用生活质量评估-8维度(AQoL-8D)工具评估MS患者的HRQoL,并量化残疾对健康状态效用值(HSUVs)以及身体和心理社会健康的影响。

方法

我们对一大组具有代表性的澳大利亚MS患者样本(n = 1,577)估计了HSUVs以及AQoL-8D的独特综合个体和超维度(身体和心理社会)得分。将这些估计值与澳大利亚一般人群规范进行比较,并按残疾严重程度细分,分为无残疾(扩展残疾状态量表[EDSS]水平:0)、轻度(EDSS:1 - 3.5)、中度(EDSS:4 - 6)和重度(EDSS:6.5 - 9.5)。多变量回归模型针对年龄、性别、MS发病类型、疾病修饰治疗(DMTs)使用状态和MS病程调整了MS残疾严重程度与HSUVs之间的关联。

结果

平均总体HSUV为0.61(95%置信区间[CI]:0.60 - 0.62),比澳大利亚人群规范低0.18个单位。HSUV随着残疾严重程度的增加而降低:无残疾、轻度、中度和重度残疾的HSUV分别为0.81(95% CI:0.80 - 0.83)、0.65(95% CI:0.63 - 0.67)、0.54(95% CI:0.52 - 0.56)和0.48(95% CI:0.46 - 0.50)。身体超维度平均得分为0.57(95% CI:0.56 - 0.58),比澳大利亚规范低0.21个单位,心理社会超维度得分为0.33(95% CI:0.32 - 0.34),比澳大利亚规范低0.16个单位。较低的HRQoL主要由独立生活(-0.23)、疼痛(-0.15)、人际关系(-0.13)、应对能力(-0.12)和自我价值感(-0.12)得分降低所驱动。

结论

MS影响HRQoL的各个方面。有效的疼痛管理以及对维持独立生活、人际关系和自我价值感的支持可显著改善MS患者的HRQoL。早期诊断以及获得负担得起的有效治疗以减缓或预防残疾累积可能也有帮助。

相似文献

1
Measuring the health-related quality of life in Australians with multiple sclerosis using the assessment of quality of life-8-dimension (AQoL-8D) multi-attribute utility instrument.使用生活质量-8维度(AQoL-8D)多属性效用工具测量澳大利亚多发性硬化症患者的健康相关生活质量。
Mult Scler Relat Disord. 2020 Sep;44:102358. doi: 10.1016/j.msard.2020.102358. Epub 2020 Jul 3.
2
Does health-related quality of life differ between people with relapse onset and progressive onset Multiple Sclerosis?复发缓解型和进展型多发性硬化症患者的健康相关生活质量是否存在差异?
Mult Scler Relat Disord. 2021 Sep;54:103138. doi: 10.1016/j.msard.2021.103138. Epub 2021 Jul 5.
3
Exploring health state utility values of parents of children with a serious illness.探索患有重病儿童的父母的健康状态效用值。
Qual Life Res. 2020 Jul;29(7):1947-1959. doi: 10.1007/s11136-020-02466-w. Epub 2020 Apr 25.
4
The impact of multiple sclerosis severity on health state utility values: Evidence from Australia.多发性硬化症严重程度对健康状态效用值的影响:来自澳大利亚的证据。
Mult Scler. 2017 Jul;23(8):1157-1166. doi: 10.1177/1352458516672014. Epub 2016 Oct 3.
5
Sensitivity of Preference-Based Quality-of-Life Measures for Economic Evaluations in Early-Stage Melanoma.早期黑色素瘤经济评估中偏好型生存质量测量的敏感性。
JAMA Dermatol. 2018 Jan 1;154(1):52-59. doi: 10.1001/jamadermatol.2017.4701.
6
Validation of the EQ-5D-5L and psychosocial bolt-ons in a large cohort of people living with multiple sclerosis in Australia.验证 EQ-5D-5L 在澳大利亚大量多发性硬化症患者中的有效性和心理附加量表。
Qual Life Res. 2023 Feb;32(2):553-568. doi: 10.1007/s11136-022-03214-y. Epub 2022 Aug 29.
7
Estimating the disutility of relapse in relapsing-remitting and secondary progressive multiple sclerosis using the EQ-5D-5L, AQoL-8D, EQ-5D-5L-psychosocial, and SF-6D: implications for health economic evaluation models.使用 EQ-5D-5L、AQoL-8D、EQ-5D-5L-psychosocial 和 SF-6D 评估复发缓解型和继发进展型多发性硬化的复发失能程度:对健康经济评价模型的影响。
Qual Life Res. 2023 Dec;32(12):3373-3387. doi: 10.1007/s11136-023-03486-y. Epub 2023 Jul 31.
8
Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D.评估澳大利亚特发性肺纤维化患者的健康相关生活质量:EQ-5D-5L 和 AQoL-8D 的比较。
Qual Life Res. 2023 Feb;32(2):473-493. doi: 10.1007/s11136-022-03205-z. Epub 2022 Aug 4.
9
A Head-to-Head Comparison of the EQ-5D-5L and AQoL-8D Multi-Attribute Utility Instruments in Patients Who Have Previously Undergone Bariatric Surgery.EQ-5D-5L与AQoL-8D多属性效用工具在既往接受过减肥手术患者中的头对头比较。
Patient. 2016 Aug;9(4):311-22. doi: 10.1007/s40271-015-0157-5.
10
Assessing health state utilities for people with myalgic encephalomyelitis/chronic fatigue syndrome in Australia using the EQ-5D-5L, AQoL-8D and EQ-5D-5L-psychosocial instruments.使用 EQ-5D-5L、AQoL-8D 和 EQ-5D-5L-心理社会工具评估澳大利亚肌痛性脑脊髓炎/慢性疲劳综合征患者的健康状态效用。
Qual Life Res. 2024 Jan;33(1):45-57. doi: 10.1007/s11136-023-03498-8. Epub 2023 Aug 10.

引用本文的文献

1
Health-related quality of life of patients with multiple sclerosis in China: a national online survey.中国多发性硬化症患者的健康相关生活质量:一项全国性在线调查。
Health Qual Life Outcomes. 2025 Jul 9;23(1):70. doi: 10.1186/s12955-025-02376-w.
2
A phase II trial examining the safety and preliminary efficacy of repetitive transcranial magnetic stimulation (rTMS) for people living with multiple sclerosis.一项评估重复经颅磁刺激(rTMS)治疗多发性硬化症患者的安全性和初步疗效的 II 期临床试验。
Trials. 2024 Sep 8;25(1):598. doi: 10.1186/s13063-024-08425-x.
3
Perceived health- related quality of life in persons with multiple sclerosis with and without a vascular comorbidity.
多发性硬化症伴或不伴血管合并症患者的健康相关生活质量感知。
Qual Life Res. 2024 Feb;33(2):573-581. doi: 10.1007/s11136-023-03546-3. Epub 2023 Nov 15.
4
Estimating the disutility of relapse in relapsing-remitting and secondary progressive multiple sclerosis using the EQ-5D-5L, AQoL-8D, EQ-5D-5L-psychosocial, and SF-6D: implications for health economic evaluation models.使用 EQ-5D-5L、AQoL-8D、EQ-5D-5L-psychosocial 和 SF-6D 评估复发缓解型和继发进展型多发性硬化的复发失能程度:对健康经济评价模型的影响。
Qual Life Res. 2023 Dec;32(12):3373-3387. doi: 10.1007/s11136-023-03486-y. Epub 2023 Jul 31.
5
The relative contribution of co-morbidities to health-related quality of life of people with idiopathic pulmonary fibrosis using the Assessment of Quality of Life-8-Dimension multi-attribute utility instrument.使用评估健康相关生活质量-8 维度多属性效用仪器评估特发性肺纤维化患者合并症对其健康相关生活质量的相对贡献。
Qual Life Res. 2023 Jun;32(6):1609-1619. doi: 10.1007/s11136-022-03331-8. Epub 2022 Dec 26.
6
Validation of the EQ-5D-5L and psychosocial bolt-ons in a large cohort of people living with multiple sclerosis in Australia.验证 EQ-5D-5L 在澳大利亚大量多发性硬化症患者中的有效性和心理附加量表。
Qual Life Res. 2023 Feb;32(2):553-568. doi: 10.1007/s11136-022-03214-y. Epub 2022 Aug 29.
7
Safety of low-intensity repetitive transcranial magneTic brAin stimUlation foR people living with mUltiple Sclerosis (TAURUS): study protocol for a randomised controlled trial.多发性硬化症患者接受低强度重复经颅磁刺激安全性研究(TAURUS):一项随机对照试验的研究方案。
Trials. 2022 Aug 3;23(1):626. doi: 10.1186/s13063-022-06526-z.
8
Can pulse steroid therapy increase the risk of infection by COVID-19 in patients with multiple sclerosis?脉冲类固醇疗法会增加多发性硬化症患者感染 COVID-19 的风险吗?
Clin Neurol Neurosurg. 2021 Apr;203:106563. doi: 10.1016/j.clineuro.2021.106563. Epub 2021 Feb 15.